Philipp E Scherer
Overview
Explore the profile of Philipp E Scherer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
448
Citations
31809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Perez-Leighton C, Kerr B, Scherer P, Baudrand R, Cortes V
Biol Rev Camb Philos Soc
. 2023 Dec;
99(3):653-674.
PMID: 38072002
Nutritional, endocrine, and neurological signals converge in multiple brain centres to control feeding behaviour and food intake as part of the allostatic regulation of energy balance. Among the several neuroendocrine...
22.
Zhao S, Lin Q, Xiong W, Li L, Straub L, Zhang D, et al.
Sci Transl Med
. 2023 Nov;
15(723):eade8460.
PMID: 37992151
Despite their high degree of effectiveness in the management of psychiatric conditions, exposure to antipsychotic drugs, including olanzapine and risperidone, is frequently associated with substantial weight gain and the development...
23.
Zhao S, Li N, Xiong W, Li G, He S, Zhang Z, et al.
Diabetes
. 2023 Nov;
73(2):197-210.
PMID: 37935033
Article Highlights:
24.
Furber E, Hyatt K, Collins K, Yu X, Droz B, Holland A, et al.
Diabetes
. 2023 Nov;
73(2):292-305.
PMID: 37934926
Article Highlights:
25.
Lebek S, Caravia X, Straub L, Alzhanov D, Tan W, Li H, et al.
J Clin Invest
. 2023 Oct;
134(1).
PMID: 37856214
Cardiovascular diseases are the most common cause of worldwide morbidity and mortality, highlighting the necessity for advanced therapeutic strategies. Ca2+/calmodulin-dependent protein kinase IIδ (CaMKIIδ) is a prominent inducer of various...
26.
Gliniak C, Pedersen L, Scherer P
J Endocrinol
. 2023 Oct;
259(3).
PMID: 37855264
The prevalence of obesity is increasing exponentially across the globe. The lack of effective treatment options for long-term weight loss has magnified the enormity of this problem. Studies continue to...
27.
Onodera T, Wang M, Rutkowski J, Deja S, Chen S, Balzer M, et al.
Nat Commun
. 2023 Oct;
14(1):6531.
PMID: 37848446
Adiponectin is a secretory protein, primarily produced in adipocytes. However, low but detectable expression of adiponectin can be observed in cell types beyond adipocytes, particularly in kidney tubular cells, but...
28.
Onodera T, Kim D, Ye R, Wang M, Chen S, Field B, et al.
Mol Metab
. 2023 Oct;
78:101821.
PMID: 37806486
The disease progression of the metabolic syndrome is associated with prolonged hyperlipidemia and insulin resistance, eventually giving rise to impaired insulin secretion, often concomitant with hypoadiponectinemia. As an adipose tissue...
29.
Agarwal A, Tunison K, Vale G, McDonald J, Li X, Scherer P, et al.
iScience
. 2023 Sep;
26(10):107806.
PMID: 37752957
Genetic loss of in humans and mice results in congenital generalized lipodystrophy with near-total loss of adipose tissue and predisposition to develop insulin resistance, diabetes mellitus, hepatic steatosis, and hypertriglyceridemia....
30.
Kruglikov I, Scherer P
Nat Rev Endocrinol
. 2023 Sep;
19(12):679-680.
PMID: 37696916
No abstract available.